Aubrey Watkins III, Ph.D., M.S. is an accomplished professional in corporate development and business management within the biotechnology and pharmaceutical sectors. Currently serving as Vice President of Corporate Development at The Jackson Laboratory since February 2024, Watkins also holds board membership at BioHealth Innovation, Inc., and holds a senior director position at Emergent BioSolutions. Previously, Watkins played key roles at Merck, including Director of Business Development & Licensing, and was a member of both the Scientific Advisory Committee and Leadership Council at The Wistar Institute. Expertise includes global procurement, sourcing initiatives, and risk management, underscored by a strong educational background with degrees in Biochemistry and Biophysics, Molecular Pharmacology, and Pharmacology from the University of Pittsburgh and Thomas Jefferson University.